products
manufactured and
sold annually
companies
under the Dadachanji Group for
manufacturing, packaging and technology
years
of experience in the pharmaceutical
industry, supplying worldwide
Industry
Headquartered in Mumbai
The Dadachanji Group of Companies is a diversified group with varied business Interests in Pharmaceuticals and Biotechnology, Primary and Secondary Packaging, Medical Devices, Machine Building, Automation, Robotics, and Sterile Processing.
Read MoreLegacy
Kairus Dadachanji
A visionary growing India’s pharmaceutical manufacturing industry.
Read MoreIndustry
Headquartered in Mumbai
Diversified group with business interests in Pharmaceuticals, Biotechnology, Machine Building, Medical Devices, Automation, Packaging, Sterile Processing and Aviation.
Read MoreOverview
Where Quality Meets Quantity
For over 30 years, the Dadachanji Group of Companies has been a premium manufacturer of pharmaceutical products. With innovative, tech-driven solutions at the helm of its approach, each product, from a billion injection doses to customized medical machines, values quality in development and quantity in production.
Growing from strength to strength
From Kaisha Packaging to Sovevax Biologics, the Dadachanji Group of Companies continues
to dominate its
presence in the pharmaceutical industry, adding innovation,
automation and robotics to its diverse portfolio.
-
Kaisha Lifesciences
A young and innovative pharmaceutical company that strives to provide high quality medication to patients worldwide.
Read More -
Kaisha Packaging
A premium manufacturer of aluminium seals for injection vials and plastic articles for the pharmaceutical industry.
Read More -
Kairish Innotech
A technology-driven company that specializes in designing and manufacturing customized machines, medical devices, robotics, and sterile processing.
Read More -
Sovereign Pharma
A WHO GMP Geneva certified manufacturing facility for terminally sterilized and aseptically filled injectables.
Read More
Making A Mark, Globally
With over 1.8 billion products manufactured and sold annually, the Dadachanji Group of Companies has strongly established its presence across the globe, now delivering to 50+ countries.
Mumbai , India
The Dadachanji Group of Companies is headquarterd in Mumbai, India, with its roots in Daman.
In The News
Budget 2021: Vaccine firms, ancillaries look at strong demand on govt's ₹35,000-cr procurement plan
Vaccine manufacturers and ancillaries are anticipating a strong demand from the government for Covid-19 vaccines alone after the government announced its plans to procure ₹35,000 crore worth of jabs, an amount estimated to be enough to vaccinate roughly half of the country's population.
India's largest vial maker expects sales to triple on COVID-19 vaccine ramp up
Indian drug vial maker Schott Kaisha is expecting annual vial sales for COVID-19 shots to more than triple as vaccine production, including by one of its top customers Serum Institute, increases in response to a monster second wave of infections.
Small pharma firms shine during Covid
But navigating this ebb and flow in demand are a bunch of rather low-profile companies that supply the medicines on their own or through alliances with larger drug- or vaccine-makers. And it’s not been an easy ride, as the fortunes of these medicines fluctuate with every advisory from the Government either recommending a drug for Covid-19 treatment or dropping it entirely from the list.
Serum Institute Buys 50 Pc Stake in Pharma Packaging Firm Schott Kaisha
Vaccine major Serum Institute of India has acquired 50 per cent stake in pharma packaging firm Schott Kaisha to become a joint venture partner of Germany's specialty glass company Schott AG. Serum Institute has acquired stake from former co-owners Kairus Dadachanji and Shapoor Mistry, Schott and Serum Institute of India said in a joint statement.
Budget 2021: Vaccine firms
Vaccine manufacturers and ancillaries are anticipating a strong demand from the government for Covid-19 vaccines
India's largest vial maker
Indian drug vial maker Schott Kaisha is expecting annual vial sales for COVID-19 shots to more than triple as vaccine production
Pharma shine during Covid
The surge in demand for medicines to treat Covid-19 has been intense and with life-and-death consequences for patients
Serum Institute Buys 50 Pc Stake in Pharma
Serum Institute has acquired stake from former co-owners Kairus Dadachanji and Shapoor Mistry